ROTATOR CUFF TENDINOPATHY
Clinical trials for ROTATOR CUFF TENDINOPATHY explained in plain language.
Never miss a new study
Get alerted when new ROTATOR CUFF TENDINOPATHY trials appear
Sign up with your email to follow new studies for ROTATOR CUFF TENDINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shoulder pain drug trial halted early
Symptom relief TerminatedThis study tested whether the drug secukinumab could reduce pain and improve function in adults with moderate to severe rotator cuff tendinopathy, a common shoulder condition. Participants received either the drug or a placebo for 24 weeks. The trial was terminated early, and res…
Matched conditions: ROTATOR CUFF TENDINOPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New drug aimed at shoulder pain fails to complete trial
Symptom relief TerminatedThis study tested the drug secukinumab against a placebo in 60 adults with moderate to severe rotator cuff tendinopathy, a painful shoulder condition. The goal was to see if secukinumab could improve symptoms and shoulder function over 24 weeks. However, the trial was terminated …
Matched conditions: ROTATOR CUFF TENDINOPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC